dapagliflozin
Showing 26 - 50 of 219
Heart Failure Trial in Shatin (Dapagliflozin)
Not yet recruiting
- Heart Failure
- Dapagliflozin
-
Shatin, Hong KongThe Chinese University of Hong Kong
Feb 24, 2023
Alzheimer Trial in Kansas City (Dapagliflozin, Placebo)
Active, not recruiting
- Alzheimer Disease
- Dapagliflozin
- Placebo
-
Kansas City, KansasUniversity of Kansas Medical Center
Apr 11, 2022
Type2diabetes, Coronary Artery Disease Trial in Gurgaon (Dapagliflozin, Glargine)
Recruiting
- Type2diabetes
- Coronary Artery Disease
- Dapagliflozin
- Glargine
-
Gurgaon, Haryana, IndiaDivision Of Endocrinology and Diabetes, Medanta The Medicity
Jul 29, 2022
Diabetes, Type 2, Endothelial Dysfunction Trial in Boston (Dapagliflozin, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- Endothelial Dysfunction
- Dapagliflozin
- Placebo
-
Boston, MassachusettsBU School of Medicine Evans 748
Jun 1, 2022
Type 1 Diabetes Trial in Kuwait City (drug, other, procedure)
Not yet recruiting
- Type 1 Diabetes
- Liraglutide / Semaglutide
- +4 more
-
Kuwait City, Al Asimah, KuwaitDasman Diabetes Institute
Jan 8, 2023
Type 2 Diabetes, Myocardial Fibrosis, Myocardial Inflammation Trial in Seattle (dapagliflozin, Placebo)
Completed
- Type 2 Diabetes Mellitus
- +2 more
- dapagliflozin
- Placebo
-
Seattle, WashingtonUniversity of Washington
Jan 9, 2023
Type2 Diabetes Trial in Malmö (Semaglutide, Dapagliflozin)
Active, not recruiting
- Type2 Diabetes
- Semaglutide
- Dapagliflozin
-
Malmö, Skane, SwedenAnders Rosengrentest
Mar 25, 2022
Steatosis, Liver, Type2 Diabetes Trial in Wien (Exenatide, Exenatide matching Placebo, Dapagliflozin)
Completed
- Steatosis, Liver
- Type2 Diabetes
- Exenatide
- +2 more
-
Wien, AustriaAbt. für Endokrinologie & Stoffwechsel, Univ. Klin f. Innere Med
Apr 8, 2022
Diabetes, Type 2 Trial in San Antonio (Placebo, Exenatide, Dapagliflozin)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Placebo
- +3 more
-
San Antonio, TexasUniversity Health System Texas Diabetic Institute
Apr 28, 2022
Heart Failure, Diabetes Trial in Atlanta, New Orleans, Philadelphia (Dapagliflozin, Placebo)
Completed
- Heart Failure
- Diabetes
- Dapagliflozin
- Placebo
-
Atlanta, Georgia
- +2 more
Mar 17, 2022
Italian Heart Failure Being Treated With Dapagliflozin in
Recruiting
- Heart Failure, Reduced Ejection Fraction
- Dapagliflozin
-
Brescia, BS, Italy
- +10 more
Aug 12, 2022
Kidney Transplantation, Diabetes, Type 2, Diabetes Complications Trial in Sao Paulo (Dapagliflozin, Placebo)
Recruiting
- Kidney Transplantation
- +2 more
- Dapagliflozin
- Placebo
-
Sao Paulo, BrazilHospital das Clinicas - FMUSP
Feb 18, 2022
Chronic Kidney Diseases Trial (Dapagliflozin)
Not yet recruiting
- Chronic Kidney Diseases
- Dapagliflozin
- (no location specified)
Jan 18, 2022
Type2 Diabetes, Remodeling, Ventricular Trial in Wonju (Dapagliflozin, Gemigliptin)
Recruiting
- Type2 Diabetes
- Remodeling, Ventricular
- Dapagliflozin
- Gemigliptin
-
Wonju, Gangwondo, Korea, Republic ofYonsei University Wonju College of Medicine
Apr 3, 2022
Type 1 Diabetes, Diabetic Ketoacidosis Trial in Hanover (Dapagliflozin, Placebo oral tablet, Stress)
Recruiting
- Type 1 Diabetes
- Diabetic Ketoacidosis
- Dapagliflozin
- +3 more
-
Hanover, Lower Saxony, GermanyKinder- und Jugendkrankenhaus AUF DER BULT
Aug 3, 2022
Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Dapagliflozin, BIOSENSE meters)
Completed
- Pancreas Cancer
- +2 more
- Dapagliflozin
- BIOSENSE meters
-
Saint Louis, MissouriWashington University School of Medicine
Dec 20, 2022
Chronic Kidney Disease With High Proteinuria Trial in Worldwide (Zibotentan/Dapagliflozin, Dapagliflozin)
Not yet recruiting
- Chronic Kidney Disease With High Proteinuria
- Zibotentan/Dapagliflozin
- Dapagliflozin
-
Bakersfield, California
- +99 more
Oct 17, 2023
SLE, Lupus Nephritis, SGLT2 Inhibitors Trial in Mansoura (dapagliflozin, )
Active, not recruiting
- SLE
- +2 more
- dapagliflozin
- placebo
-
Mansoura, EgyptUrology and Nephrology Center
Feb 18, 2023
Acute Heart Failure, Heart Failure Trial in Boston (Dapagliflozin, Placebo)
Recruiting
- Acute Heart Failure
- Heart Failure
- Dapagliflozin
- Placebo
-
Boston, MassachusettsTIMI Study Group
Dec 9, 2021
Cardiorenal Syndrome Trial in New Haven (Dapagliflozin)
Not yet recruiting
- Cardiorenal Syndrome
- Dapagliflozin
-
New Haven, ConnecticutYale New Haven Hospital
Oct 26, 2023
Atrial Fibrillation Trial in United States (dapagliflozin, Placebo)
Recruiting
- Atrial Fibrillation
- dapagliflozin
- Placebo
-
Portland, Maine
- +4 more
Apr 21, 2022
Type 2 Diabetes, Hypertension Trial in New Orleans (Dapagliflozin, Sulfonylurea, Placebo)
Completed
- Type 2 Diabetes
- Hypertension
- Dapagliflozin
- Placebo
-
New Orleans, LouisianaTulane University
Oct 5, 2022
Anemia, Heart Failure Trial in Xiangtan (Dapagliflozin, Placebo)
Recruiting
- Anemia
- Heart Failure
- Dapagliflozin
- Placebo
-
Xiangtan, Hunan, ChinaXiangtan Central Hospital
Oct 27, 2021